In-Gyu Lee
Director/Miembro de la Junta en NOVMETAPHARMA CO., LTD. .
Perfil
In-Gyu Lee is currently a Director at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He is also a Professor at Kyungpook National University, a position he has held since 2005.
He received his undergraduate, graduate, and doctorate degrees from Kyungpook National University.
Cargos activos de In-Gyu Lee
Empresas | Cargo | Inicio |
---|---|---|
NOVMETAPHARMA CO., LTD. | Director/Miembro de la Junta | 13/12/2017 |
Kyungpook National University | Corporate Officer/Principal | 01/04/2005 |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Director/Miembro de la Junta | - |
Formación de In-Gyu Lee.
Kyungpook National University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Bolsa de valores
- Insiders
- In-Gyu Lee